Devon J. Shedlock

Chief Scientific Officer of Cell Therapies at Poseida Therapeutics, Inc.

Devon J. Shedlock

Devon J. Shedlock

Chief Scientific Officer of Cell Therapies at Poseida Therapeutics, Inc.

Biography

Devon J. Shedlock, Ph.D.

Senior Vice President, Research & Development

Dr. Shedlock is the Senior Vice President of Research & Development at Poseida Therapeutics. He was among the first employees at Poseida, has extensive experience in the field of T-cell immunology, and was formerly an adjunct assistant professor of pathology & laboratory medicine at the Perelman School of Medicine, as well as associate director of the T-Cell Engineering Laboratory that is part of Carl June’s group at the University of Pennsylvania. Prior to his work developing engineered T lymphocyte-based therapies for treating cancer, he led a team in the development of DNA vaccines against numerous pathogens from the preclinic to clinical trials, including those targeting the human herpes viruses and a vaccine for Ebola. He also established numerous animal models for evaluation of vaccine immunogenicity and efficacy, molecular adjuvants, genetic optimization strategies, and advanced delivery technologies. Previously, he studied the mechanisms of antibody-mediated neutralization of Ebola as a postdoctoral fellow at the Vaccine Research Center, National Institutes of Health. Dr. Shedlock received his Ph.D. from the University of Pennsylvania, investigating the role of helper T cells in the generation of immunity, and his B.S. with honors in biology from Ursinus College.

Overview
RelSci Relationships

33

Contact Data
Trying to get in touch with Devon J. Shedlock? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Devon J. Shedlock likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Executive Officer & Founder at Poseida Therapeutics, Inc.

Relationship likelihood: Strong

President & Chief Business Officer at Poseida Therapeutics, Inc.

Relationship likelihood: Strong

Chief Medical Officer at Poseida Therapeutics, Inc.

Relationship likelihood: Strong

Chief Financial Officer at Poseida Therapeutics, Inc.

Relationship likelihood: Strong

Chief Operating Officer at Poseida Therapeutics, Inc.

Relationship likelihood: Strong

General Counsel, Chief Compliance Officer & Corporate Secretary at Poseida Therapeutics, Inc.

Relationship likelihood: Strong

Chief People & Administration Officer at Poseida Therapeutics, Inc.

Relationship likelihood: Strong

Chief Executive Officer & Director at AFYX Therapeutics AS

Relationship likelihood: Strong

MD PhD at Dana-Farber Cancer Institute, Inc.

Relationship likelihood: Average

Vice President, Intellectual Property at Poseida Therapeutics, Inc.

Relationship likelihood: Average

Paths to Devon J. Shedlock
Potential Connections via
Relationship Science
You
Devon J. Shedlock
Chief Scientific Officer of Cell Therapies at Poseida Therapeutics, Inc.
Career History
Chief Scientific Officer of Cell Therapies
Current

Poseida Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of non-viral gene engineering technologies for the treatment of hematological malignancies and solid tumors. Its products pipeline include autologous and allogeneic chimeric antigen receptor T cell, or CAR-T. The company was founded by Eric M. Ostertag in December 2014 and is headquartered in San Diego, CA.

Other Affiliations

Devon J. Shedlock is affiliated with Poseida Therapeutics, Inc.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Devon J. Shedlock. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Devon J. Shedlock's profile does not indicate a business or promotional relationship of any kind between RelSci and Devon J. Shedlock.